The chemistry and biological effects of thioflavones

J Dong, Q Zhang, Q Meng, Z Wang… - Mini reviews in …, 2018 - ingentaconnect.com
Thioflavone derivatives are the thio analogs of the core constituent of the natural product
class of flavones. Based on the position and oxidation level of sulfur, they can be divided …

[HTML][HTML] Targeting pancreatic cancer cell plasticity: The latest in therapeutics

JM Smigiel, N Parameswaran, MW Jackson - Cancers, 2018 - mdpi.com
Mortality remains alarmingly high for patients diagnosed with pancreatic ductal
adenocarcinoma (PDAC), with 93% succumbing to the disease within five years. The vast …

Probing the global kinome and phosphoproteome in Chlamydomonas reinhardtii via sequential enrichment and quantitative proteomics

EG Werth, EW McConnell, TSK Gilbert… - The Plant …, 2017 - Wiley Online Library
The identification of dynamic protein phosphorylation events is critical for understanding
kinase/phosphatase‐regulated signaling pathways. To date, protein phosphorylation and …

Comprehensive clinical trial data summation for BRAF‐MEK inhibition and checkpoint immunotherapy in metastatic melanoma

JJ Luke - The oncologist, 2019 - academic.oup.com
Background Immune checkpoint inhibitors, along with BRAF and MEK inhibitors, have
dramatically changed the management of and outlook for patients with metastatic …

[HTML][HTML] ABL1/2 and DDR1 drive MEKi resistance in NRAS-mutant melanomas by stabilizing RAF/MYC/ETS1 and promoting RAF homodimerization

A Lyon, R Tripathi, C Meeks, D He, Y Wu, J Liu… - Cancers, 2023 - mdpi.com
Simple Summary NRAS-mutant melanoma is a highly aggressive subtype with few treatment
options. Although both BRAF-mutant and NRAS-mutant melanomas have activation of the …

mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression

T Sticz, A Molnár, Á Márk, M Hajdu, N Nagy… - Journal of clinical …, 2017 - jcp.bmj.com
Aims Tumour heterogeneity and altered activation of signalling pathways play important
roles in therapy resistance. The PI3K/Akt/mTOR signalling network is a well-known regulator …

Feedback analysis identifies a combination target for overcoming adaptive resistance to targeted cancer therapy

SM Park, CY Hwang, J Choi, CY Joung, KH Cho - Oncogene, 2020 - nature.com
Targeted drugs aim to treat cancer by directly inhibiting oncogene activity or oncogenic
pathways, but drug resistance frequently emerges. Due to the intricate dynamics of cancer …

Preclinical evaluation of a novel orally available SRC/Raf/VEGFR2 inhibitor, SKLB646, in the treatment of triple-negative breast cancer

MW Zheng, CH Zhang, K Chen, M Huang, YP Li… - Molecular Cancer …, 2016 - AACR
Triple-negative breast cancer (TNBC) is the most aggressive and deadly breast cancer
subtype. To date, chemotherapy is the only systemic therapy and prognosis remains poor …

KIF22 promotes development of pancreatic cancer by regulating the MEK/ERK/P21 signaling axis

R Zhang, L Ma, Y Wei, K Wei, T Song… - BioMed Research …, 2022 - Wiley Online Library
The study is aimed at exploring the potential biological process and molecular mechanism
of KIF22 involved in the development and progression of pancreatic cancer. First, we used …

Upregulation of KIN17 is associated with non-small cell lung cancer invasiveness

Y Zhang, S Huang, H Gao, K Wu… - Oncology …, 2017 - spandidos-publications.com
Kin17 DNA and RNA binding protein (Kin17) is a highly conserved protein that participates
in DNA replication, DNA repair and cell cycle progression. Recently, the tumor‑promoting …